Balchem Corp
BCPC
NASDAQ·Basic Materials·Chemicals - Specialty·Mkt cap $5.5B
$171.61
▼ -0.08%
P/E
33.65
Mkt Cap
$5.5B
52-Wk Range
$139.17–$183.90
52-Week Range
$139.17 - $183.90
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 5.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary microencapsulation and chelation technology platforms with high barriers to entry
- Diversified customer base across pharma, food, animal health, and medical device sterilization reduces concentration risk
- Essential product applications in regulated industries create sticky, long-term customer relationships
- Integrated manufacturing capabilities and supply chain control support margin expansion
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Rising global demand for fortified foods and nutritional supplements driven by health-conscious consumers
Value
Significant premium - growth priced in
Momentum
Strong
+8.1% over 3m
Quality
Stable
Strong fundamentals
Dividend
Modest
0.56% yield
Smart-money signal
Who's buying BCPC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 20, 2026
JUL 31, 2026
Reported EPS of $1.40 vs $1.27 consensus (+10.2% surprise). Revenue of $284.0M vs $268.5M expected (+5.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+10.2%
Revenue trend · last 8Q
—
+5%
+5%
+9%
+12%
+10%
+8%
+11%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$239.9M
$240.0M
$250.5M
$255.5M
$267.6M
$263.6M
$270.7M
$284.0M
Margins · last 8Q
Gross
36.5%
Operating
20.9%
Profit
15.7%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Aug 3, 2026
vs Industry
How BCPC stacks vs Chemicals - Specialty
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related